The Minneapolis City Council approved file 2026-01143 ("Expands buprenorphine clinics for opioid addiction"), by a recorded vote of 12 to 0. Last action: October 20, 2026.
Minneapolis file 2026-01143, before the Minneapolis City Council. Passed as of 2026-10-20.
Get medication for opioid addiction closer to home People with opioid use disorder can now receive long-acting injectable buprenorphine at Neighborhood HealthSource, Fairview Recovery, and Red Door clinics instead of traveling to distant hospitals.
Reduces emergency room visits and overdose deaths Expanding clinic-based medication treatment typically lowers hospital emergency room use, reduces overdose deaths, and helps people stay in jobs and housing while receiving care.
Access limited to three specific neighborhood clinics The program only covers these three clinics and ends December 31, 2027; people in other areas or after that date may not have the same access unless the city renews the agreement.
Authorizing a Memorandum of Understanding (MOU) between the City of Minneapolis Health Department and Neighborhood HealthSource Central Clinicto expand access to long-acting injectable buprenorphine for people with opioid use disorder until December 31, 2027.
Read the official record for 2026-01143
See everything up for a vote · This week in Minneapolis · See what we have filed with the clerk